Nurix Therapeutics
Vice President, Medical Affairs – Hematology-Oncology
Brisbane, CA · Exec
Sponsorship not specified$348k-$399kDetected 17 days ago
Patient CareResearchLeadershipCommunicationCollaborationPublic Speaking
Stay score
odds of building a lasting career here
59Sponsors, lottery-bound
Cap-exempt (no lottery)0
Sponsors this role80
Entry-level history0
PERM / green-card track0
Lottery odds (Level IV)94
Fits your clock70
Sponsors, but it's cap-subject — you still face the weighted lottery (~61% per draw at Level IV). Good if you win; have a cap-exempt backup on your list.
Lottery odds assume a STEM candidate.
Personalize to your clock →Employer immigration record
from this employer's Department of Labor filings
Files H-1B transfers
2 transfer filings in the last year, covering 2 workers. Median labor-condition decision: 8 days. An employer that already files transfers is one that can take over an existing H-1B.
Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.
Community outcomes
No reports yet — be the first to help the next applicant.
About the role
- Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease.
- The role will play a central role in shaping the scientific and medical strategy for Nurix's targeted protein degradation portfolio and helping define the company's external scientific leadership in hematologic malignancies.
- This leader will contribute broadly to portfolio strategy, lifecycle planning, and enterprise-level decision making as a member of the senior leadership team.
Responsibilities
- Expand and lead a high-performing MSL organization focused on credible scientific exchange, compliant insight capture, and strong engagement with key external experts, investigators, and treatment centers.
- Lead external engagement in hematologic malignancies, including advisory boards, investigator relationships, disease-area thought leader engagement, and interactions with cooperative groups and broader scientific communities.
- Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases.
Requirements
- MD, PhD, DO, or PharmD required
Nice to have
- Experience in highly innovative therapeutic platforms, first-in-class mechanisms, or rapidly evolving treatment landscapes strongly preferred.
Compensation
- $348,000 - $399,000
Benefits
- Lead and scale the Medical Affairs function to support the progression of Nurix's hematology-oncology programs into late-stage clinical development and future commercial readiness.
- Own the overall Medical Affairs strategy for the hematology-oncology portfolio, ensuring alignment with development plans, portfolio priorities, and corporate objectives.
- Lead development of the scientific platform and differentiated medical narrative for Nurix hematology-oncology programs within rapidly evolving treatment landscapes.
- Partner closely with Clinical Development to shape late-stage medical strategy, including data generation priorities, scientific narrative, external engagement plans, and lifecycle opportunities.
- Develop and execute integrated medical plans across field medical, scientific communications, publications, medical education, medical information, insight gathering, and evidence generation.
- Direct publication and scientific communication strategy for key clinical data, congress presentations, medical content, symposia, and educational initiatives.
- Partner with Commercial and Market Access to ensure medical strategy informs launch readiness, access planning, scientific platform development, training initiatives, and broader commercialization strategy.
- Monitor the external hematology-oncology landscape, including standard-of-care evolution, competitor data, treatment guidelines, and emerging scientific trends, and translate insights into actionable medical strategy.
- Ensure all Medical Affairs activities are conducted in compliance with applicable legal, regulatory, and company standards.
- Provide medical and scientific leadership to executive governance discussions related to portfolio prioritization, lifecycle strategy, label expansion opportunities, external partnerships, and commercialization readiness.
- Support global Medical Affairs planning and coordination, including scientific congress strategy, evidence generation activities, and external engagement initiatives across key regions.
- 15+ years of biopharmaceutical Medical Affairs experience with significant leadership responsibility, including direct accountability for launch and post-approval
Apply directly at Nurix Therapeutics →Create a free account for alerts like thisView Nurix Therapeutics immigration profile
This listing is sourced directly from Nurix Therapeutics's careers page and normalized into a canonical job model.